acquired
Stage
About
Nuvalent, Inc develops targeted therapies for cancer patients, focusing on drugs for ROS1-, ALK-, and HER2-positive non-small cell lung cancer and other solid tumors.
Explore Nuvalent, Inc's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.